Strecker Stent as a Bailout Device Following Percutaneous Transluminal Coronary Angioplasty

Reifart, Nicolaus; Langer, Alois; Störger, Hans; Schwarz, Franz; Preusler, W; Hofmann, Manfred

doi:10.1111/j.1540-8183.1992.tb00411.x

Cited by 23 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite initial encouraging results (subacute closure in 0.6% of the 174 patients reported in 1990 by Schatz) [7], it has rapidly proved to be a failure, the rate of subacute thrombosis after 1 month rising to 10% with the PalmazSchatz stent [9], 24% with the Wallstent [10], 10% with the Wiktor stent [11], and 11.7% with the GianturcoRoubin flexible coil [12]. Higher complication rates (from 20 to 30%) were established when stent implantation was realized after occlusive dissection [13,14]. These subacute thromboses with their catastrophic complications (myocardial infarction and urgent bypass surgery) have led accordingly to recommend the withdrawal of the arterial sheath under the cover of a high blood heparin level.…”

Section: Anticoagulant or Antiplatelet Therapy After Stent Implantation?mentioning

confidence: 99%

Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: Prospective study of 1,051 consecutive patients

Barragan

Sainsous²,

Silvestri

et al. 1997

Cathet. Cardiovasc. Diagn.

View full text Add to dashboard Cite

Section: Anticoagulant or Antiplatelet Therapy After Stent Implantation?mentioning

confidence: 99%

Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: Prospective study of 1,051 consecutive patients

Barragan

Sainsous²,

Silvestri

et al. 1997

Cathet. Cardiovasc. Diagn.

View full text Add to dashboard Cite

“…Several designs of the former stents have been tested and include Palmaz-Schatz [85,160], Roubin [155], Strecker [148,184], Wiktor [13], Freedom [199], Cordis [90], ACS multi-link [178] and others; PalmazSchatz stents are the most commonly used stents in clinical practice, to date. Among the self-expandable stents, Wallstent [156,188] and the Nitinol InStent [9] have been tested.…”

Section: Intravascular Stentsmentioning

confidence: 99%

Interventional Pediatric Cardiology: State of the Art and Future Directions

Rao

1998

Pediatr Cardiol

View full text Add to dashboard Cite

Although the interventional pediatric cardiology began in the early 1950s, it was not until the mid-1980s that a full spectrum of transcatheter interventions in children could be undertaken including balloon atrial septostomy which has been in usage since 1966. Enormous developments have occurred even from the mid-1980s to date. In this review, current state-of-the-art for each broad area of therapeutic catheterization is presented. A large variety of lesions could be opened-up or closed, as the case may be and the results of these interventions were either similar to or better than those reported for the alternative surgical therapy. Indeed, therapeutic catheterization techniques have replaced the conventional surgery for many lesions and are threatening to do so for others. However, long-term follow-up results are scanty and are needed. Further miniaturization of catheters/sheaths used in interventional pediatric cardiology and development of new technology for the lesions which are not amenable to currently available transcatheter methods are awaited. The future seems to be bright for interventional pediatric cardiology.

show abstract

“…A limited number of stents are currently being clinically investigated. Among them are the balloon expandable Palmaz Schatz Roubin [ 5 ,61,Wiltor [7, 81, and the Strecker [9] stents. In contrast to the wide variety of balloon expandable stents, the Wallstent is the only largely tested self-expandable stent [ 101.…”

Section: Introductionmentioning

confidence: 99%

Self‐Expandable nitinol stent for cardiovascular applications: canine and human experience

Beyar¹,

Shofti²,

Grenedier³

et al. 1994

Cathet. Cardiovasc. Diagn.

View full text Add to dashboard Cite

The initial experimental and clinical experience with the cardiovascular self-expandable Nitinol stent (vascular and coronary versions) is described. The stent is designed as a helical coil with two terminal balls that are used for restraining it on the delivery catheter. Upon release, the stent self-expands immediately. A temporary stent version continues with a long wire that can be removed by pulling it as a straight wire through a small profile catheter. The stent uncoils in its own groove upon removal, a relatively atraumatic procedure. The stents have been studied in dogs and in peripheral arteries in patients. The results show a transient nonocclusive proliferative response to the stent that is maximal at 3-6 mo. The removability of the permanent stent has been proven in dogs. The preliminary results in patients are encouraging and demonstrate its feasibility for permanent and potentially temporary arterial support.

show abstract

Strecker Stent as a Bailout Device Following Percutaneous Transluminal Coronary Angioplasty

Cited by 23 publications

References 6 publications

Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: Prospective study of 1,051 consecutive patients

Coronary artery stenting without anticoagulation, aspirin, ultrasound guidance, or high balloon pressure: Prospective study of 1,051 consecutive patients

Interventional Pediatric Cardiology: State of the Art and Future Directions

Self‐Expandable nitinol stent for cardiovascular applications: canine and human experience

Contact Info

Product

Resources

About